Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of topical delgocitinib cream in Chinese adolescents and adults with moderate to severe chronic hand eczema
CTR20232104Phase 3Completed
- Sponsor
- LEO Pharma
- Start
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of delgocitinib in chronic hand dermatitis (CHE), sponsored by LEO Pharma. Started Jul 2023; status: completed.
02
Drugs
delgocitinib
03
Conditions
chronic hand dermatitis (CHE)
Beyond the preview
Go deeper on CTR20232104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20232104.